With recent news on the spread of Coronavirus (COVID-19), many Tandem users have expressed concern about the ongoing availability of infusion sets, cartridges, and other supplies. Here’s a quick Q&A on how we’re working to protect our customers, our supply chain, and our employees.

You can initiate your request for a software update in the easy-to-use t:connect portal. Read on to learn more about the steps in the process, and general guidelines for how long each can take.

We've created a series of short instructional videos to highlight some of the features of the t:slim X2 insulin pump. Check out the first videos in this series!

The year is winding down. If you have funds sitting in your flexible spending account (FSA) or a maxed-out insurance deductible, there could be a new t:slim X2 insulin pump out there with your name on it. You can wait for the next big approval by the FDA to order your pump, or you can boost your chances of getting your t:slim X2 pump for less out-of-pocket by taking a strategic, time-sensitive approach. With Tandem Diabetes Care, there’s no need to wait. Since today’s t:slim X2 insulin pump is built for tomorrow’s technologies, you can purchase your t:slim X2 insulin pump now...

A lot of people with type 1 diabetes are ready to buy their first (or next) insulin pump, but when it comes to making that purchase, they’re debating whether or not they should wait for the next, big FDA-approved product before taking the plunge. Sound familiar? With Tandem Diabetes Care, there’s no need to wait...

Tandem announced its sponsorship of Project 50-in-50, a mountaineering challenge by two climbers with type 1 diabetes—Michael Shelver and Patrick Mertes. To achieve their goal, Shelver and Mertes will need to summit the highest peaks in each of the 50 United States in 50 days or less. Only two individuals have accomplished this before, none with type 1 diabetes.

Today we announced announced our sponsorship of Connected in Motion’s 2019 program calendar, featuring social and educational programing that builds community among people with type 1 diabetes. The funding will go to support Slipstream Retreats, adventure programs, and special projects in Ontario, British Columbia, the Yukon, and Alberta, Canada, including additional support for the Ontario Slipstream Retreat, hosted in partnership with Beyond Type 1.

Every day, Tandem pump users are doing their part to reduce, reuse, and recycle. As the only rechargeable insulin pumps on the market, Tandem insulin pumps have kept an estimated 4 million disposable batteries out of landfills since becoming available in 2012. We’re proud to do our small part to help reduce the number of disposable batteries going into our landfills.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its sponsorship of Beyond Type 1’s “Beyond Type Run,” an official charity partner of the 2019 TCS New York City Marathon. All Beyond Type Run team members have option to use t:slim X2 insulin pump for training and event.

Today we announced our sponsorship of BlueLoop, a care coordination resource for children with type 1 diabetes. BlueLoop, powered by the non-profit MyCareConnect Foundation, is a tool to help improve a family's ability to manage a child’s diabetes when the child is at school or away from home.

Today we announced our sponsorship of the Beyond Type 1 Snail Mail Club. Percy, the official Snail Mail mascot, will begin using the t:slim X2™ insulin pump as part of the new partnership!

On February 14, 2019, we announced that the t:slim X2™ insulin pump is the first to receive approval in a new device category called alternate controller enabled infusion (ACE) pumps. Here we break down what this REALLY means for our customers and the wider diabetes community.

We’re grateful to our distribution partners around the world helping us bring the t:slim X2™ insulin pump to you!

We're proud to announce we have been named a top workplace in San Diego by The San Diego Union-Tribune and awarded a “Future Forward” 2018 Top Workplaces honor!

We’re here to answer some questions about the recent FDA approval of the t:slim X2 Insulin Pump with Basal-IQ™ Technology. Please note these answers are intended for our customers in the United States.

The FDA-Approved t:slim X2 Insulin Pump with Basal-IQ Technology and Dexcom G6® CGM System integration has arrived.

Attention, t:slim X2™ and t:slim G4™ Pump users! If you’re enjoying the CGM integration on your pump, please be sure to specifically request the CGM sensors compatible with your device next time you order supplies from Dexcom. If they don’t know you use an integrated Tandem device, you may automatically receive their new G6 system with your next order.

The AutoSoft™ XC infusion set is the t:lock™ equivalent to the Inset™ infusion set formerly distributed by Animas.

We are pleased to announce an enhancement to our Therapy Timeline report in t:connect. The Therapy Timeline will now include Dexcom® CGM readings when a CGM enabled Tandem pump is uploaded to t:connect.